El Paso-based Pediatric Urgent Care Clinic Emerges as Prominent Trial Site for Critical Pediatric-based Moderna Vaccine Trial Supported by NIAID & BARDA

El Paso-based Pediatric Urgent Care Clinic Emerges as Prominent Trial Site for Critical Pediatric-based Moderna Vaccine Trial Supported by NIAID & BARDA

Moderna recently announced that the first participants in the Phase 2/3 KidCOVE study were dosed in what is the first vaccine trial involving children aged six months to 12 years old. Focusing on the COVID-19 vaccine known as mRNA-1273, the study is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS). TrialSite recently introduced the two part open label, dose-escalation, age de-escalation and randomized observer-blind, placebo-controlled expansion study that evaluates the safety, tolerability and reactogenicity and effectiveness of two doses of the experimental vaccine given 28 days apart. The sponsor will enroll in total 6,750 pediatric participants in the U.S. and Canada. While some trial sites were bypassed, others were invited to participate in this heavily watched study, including a trial site organization with an urgent care clinic called Pininos Pediatric Clinic in El Pas...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee